1. Home
  2. CAPL vs GOSS Comparison

CAPL vs GOSS Comparison

Compare CAPL & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CrossAmerica Partners

CAPL

CrossAmerica Partners

HOLD

Current Price

$20.82

Market Cap

782.2M

Sector

Energy

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$3.29

Market Cap

726.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAPL
GOSS
Founded
1992
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
782.2M
726.8M
IPO Year
2012
2019

Fundamental Metrics

Financial Performance
Metric
CAPL
GOSS
Price
$20.82
$3.29
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$8.60
AVG Volume (30 Days)
22.7K
4.0M
Earning Date
11-05-2025
11-05-2025
Dividend Yield
10.13%
N/A
EPS Growth
129.06
N/A
EPS
1.19
N/A
Revenue
$3,418,591,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$6.41
P/E Ratio
$17.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.61
$0.76
52 Week High
$25.73
$3.87

Technical Indicators

Market Signals
Indicator
CAPL
GOSS
Relative Strength Index (RSI) 56.66 51.00
Support Level $20.51 $3.37
Resistance Level $21.23 $3.87
Average True Range (ATR) 0.39 0.26
MACD 0.03 -0.03
Stochastic Oscillator 74.70 18.94

Price Performance

Historical Comparison
CAPL
GOSS

About CAPL CrossAmerica Partners

CrossAmerica Partners LP is engaged in the wholesale distribution of motor fuel and the ownership and leasing of real estate used in the retail distribution of motor fuel. The company operates through two business segments namely Wholesale and Retail. The Wholesale segment is a key revenue driver and includes the wholesale distribution of motor fuel to lessee dealers, independent dealers, commission agents, DMS, Circle K, and through company-operated retail sites. The Retail segment includes the sale of convenience merchandise items, the retail sale of motor fuel at company-operated retail sites, and the retail sale of motor fuel at retail sites operated by commission agents.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: